Read more

August 12, 2021
2 min watch
Save

VIDEO: Cyclosporine insert removes compliance issue from dry eye disease treatment

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

LAS VEGAS — In this Healio Video Perspective from the ASCRS meeting, Lee Shettle, DO, discusses results from a phase 1 trial investigating a novel hydrogel-based cyclosporine insert for the treatment of dry eye disease.